New heart valve procedure tested for leaky valve patients

NCT ID NCT06818084

Summary

This study is testing a minimally invasive procedure to replace a leaky heart valve (aortic regurgitation) in patients aged 60 and older. It compares a specific new valve system (VitaFlow Liberty) against other approved devices to see which is safer and more effective at preventing major heart problems and hospitalizations over one year. The main goal is to control the disease and improve patients' quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Changhai Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200433, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ruijin hospital, Shanghai JiaoTong University School of Medicine

    RECRUITING

    Shanghai, Shanghai Municipality, 200025, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shanghai Chest Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200030, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhongshan Hospital, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.